Prenosis and LifeBridge Health — FDA-Authorized AI for Sepsis Detection
ENTITYLifeBridge Health has deployed Prenosis' FDA-authorized AI tool to accelerate sepsis detection across its hospital network. Sepsis — a life-threatening organ dysfunction caused by dysregulated response to infection — kills an estimated 270,000 Americans annually, and early detection is the single most impactful intervention for improving survival outcomes. Each hour of delayed treatment significantly increases mortality risk. Prenosis' AI tool analyzes multiple clinical data streams to identify patients at high risk of sepsis before traditional clinical criteria are met, enabling earlier intervention. FDA authorization for the tool reflects regulatory recognition of its clinical utility and safety profile, distinguishing it from the many AI clinical decision support tools that operate without formal regulatory clearance. LifeBridge Health's deployment across its multi-hospital system represents a meaningful real-world validation of AI-assisted sepsis detection at scale. The health system's adoption decision reflects growing institutional confidence in FDA-authorized clinical AI tools as the regulatory pathway matures and post-market performance data accumulates. The Prenosis deployment is part of a broader trend of health systems adopting AI early warning systems for time-sensitive conditions including sepsis, deterioration, and cardiac events. RWJBarnabas Health's AI early warning system, which demonstrated an 18% reduction in risk-adjusted in-hospital mortality, provides…
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.